Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Myeloid sarcoma: Current approach and therapeutic options.Ther Adv Hematol. 2011; 2: 309-316
- How I treat extramedullary acute myeloid leukemia.Blood. 2011; 118: 3785-3793
- Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients.Leukemia. 2007; 21: 340-350
- Granulocytic sarcoma in nonleukemic patients.Cancer. 1986; 58: 2697-2709
- Extramedullary myeloid cell tumors in acute non- lymphocytic leukemia: a clinical review.J Clin Oncol. 1995; 13: 1800-1816
- Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.Leukemia. 2007; 21: 1566-1570
- FLT3 mutations in myeloid sarcoma.Br J Haematol. 2004; 126: 785-791
- Granulocytic sarcoma: 32 cases and review of the literature.Leuk Lymphoma. 2006; 47: 2527-2541
- Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.Leuk Res. 2017; 53: 74-81
Conflicts of Interest: None.
Authorship: All authors had access and a role in writing the manuscript.